Gabet, Brian2020-09-082020-09-082020-05https://hdl.handle.net/11299/216085University of Minnesota M.S. thesis.May 2020. Major: Medicinal Chemistry. Advisor: Gunda Georg. 1 computer file (PDF); vi, 54 pages.Currently, there is an unmet need for selective, non-hormonal male contraceptive agents. The cation channels of sperm (CatSper) are sperm-specific, voltage-gated ion channels that regulate the internal calcium (Ca2+) concentration in mature spermatozoa. These channels are activated by the alkaline environment of the female reproductive tract, resulting in an influx of Ca2+ initiating hyperactivated motility (HAM) necessary for fertilization. Mutations within CatSper, as confirmed by mouse knockout studies, lead to infertility in males with no other observable phenotypes, validating CatSper as a target for male contraception. We envision that the development of CatSper inhibitors will serve as a selective, reversible, and non-hormonal means to male contraception. A 70,000 compound high-throughput screening campaign was performed, using human sperm and a Fluorescent Imaging Plate Reader (FLIPR) assay to measure Ca2+ influx yielded seven hits with micromolar potencies. Two of these hits, compounds 1 and 2, were confirmed by electrophysiology as CatSper inhibitors and selected for structure-activity relationship studies. This thesis reports on the design, synthesis, and testing of analogs related to these two hits.enABHD2CASACatSperHyperactivated motilityMale contraceptionSpermDevelopment of Inhibitors For the Cation Channels of Sperm For Male ContraceptionThesis or Dissertation